TWEAK/Fn14 system and crescent formation in IgA nephropathy

[1]  M. Sánchez-Niño,et al.  Non-canonical NFκB activation promotes chemokine expression in podocytes , 2016, Scientific Reports.

[2]  Shao-Cong Sun,et al.  NF-κB in inflammation and renal diseases , 2015, Cell & Bioscience.

[3]  Yusuke Suzuki,et al.  Proposal of remission criteria for IgA nephropathy , 2014, Clinical and Experimental Nephrology.

[4]  L. Morando,et al.  Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments , 2014, Kidney international.

[5]  M. Sánchez-Niño,et al.  TWEAK and the progression of renal disease: clinical translation. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  A. Ramos,et al.  Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) and kidney disease , 2014, Current opinion in nephrology and hypertension.

[7]  M. Sánchez-Niño,et al.  Fn14 in podocytes and proteinuric kidney disease. , 2013, Biochimica et biophysica acta.

[8]  Yusuke Suzuki,et al.  A histologic classification of IgA nephropathy for predicting long-term prognosis: emphasis on end-stage renal disease. , 2013, Journal of nephrology.

[9]  Y. Tomino,et al.  Relationships between levels of urinary podocalyxin, number of urinary podocytes, and histologic injury in adult patients with IgA nephropathy. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[10]  M. Sánchez-Niño,et al.  TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation. , 2012, Kidney international.

[11]  P. Mundel,et al.  Cell biology and pathology of podocytes. , 2012, Annual review of physiology.

[12]  U. Berg,et al.  Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[13]  T. Ninomiya,et al.  Validation study of oxford classification of IgA nephropathy: the significance of extracapillary proliferation. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[14]  M. Sánchez-Niño,et al.  TWEAK, a multifunctional cytokine in kidney injury. , 2011, Kidney international.

[15]  Su-xia Wang,et al.  Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. , 2011, Clinical journal of the American Society of Nephrology : CJASN.

[16]  B. Julian,et al.  Validation of the Oxford classification of IgA nephropathy. , 2011, Kidney international.

[17]  M. Sánchez-Niño,et al.  The inflammatory cytokines TWEAK and TNFα reduce renal klotho expression through NFκB. , 2011, Journal of the American Society of Nephrology : JASN.

[18]  J. Carrero,et al.  Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[19]  B. Rovin,et al.  Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study , 2009, Arthritis research & therapy.

[20]  Sandrine Florquin,et al.  The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. , 2009, Kidney international.

[21]  Fernand,et al.  The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. , 2009, Kidney international.

[22]  G. Camussi,et al.  Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes , 2009, Diabetes.

[23]  C. Chung,et al.  The monocyte chemoattractant protein-1/CCR2 loop, inducible by TGF-beta, increases podocyte motility and albumin permeability. , 2009, American journal of physiology. Renal physiology.

[24]  Yasuhiko Tomino,et al.  Revised equations for estimated GFR from serum creatinine in Japan. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  Irene Jarchum,et al.  TNF-like weak inducer of apoptosis (TWEAK) induces inflammatory and proliferative effects in human kidney cells. , 2009, Cytokine.

[26]  J. Winkles.  The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targeting , 2008, Nature Reviews Drug Discovery.

[27]  M. Sánchez-Niño,et al.  The cytokine TWEAK modulates renal tubulointerstitial inflammation. , 2008, Journal of the American Society of Nephrology : JASN.

[28]  Y. Sado,et al.  Podocytes contribute to the formation of glomerular crescents. , 2008, Journal of the American Society of Nephrology : JASN.

[29]  Yusuke Suzuki,et al.  Amelioration of crescentic glomerulonephritis by RhoA kinase inhibitor, Fasudil, through podocyte protection and prevention of leukocyte migration. , 2008, The American journal of pathology.

[30]  P. Dentelli,et al.  The monocyte chemoattractant protein-1/cognate CC chemokine receptor 2 system affects cell motility in cultured human podocytes. , 2007, The American journal of pathology.

[31]  S. Shankland,et al.  Podocytes in culture: past, present, and future. , 2007, Kidney international.

[32]  B. Rovin,et al.  Urinary TWEAK and the activity of lupus nephritis. , 2006, Journal of autoimmunity.

[33]  M. Sánchez-Niño,et al.  Cytokine cooperation in renal tubular cell injury: the role of TWEAK. , 2006, Kidney international.

[34]  P. Tipping,et al.  T cells in crescentic glomerulonephritis. , 2006, Journal of the American Society of Nephrology : JASN.

[35]  Yasuhiko Tomino,et al.  Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling , 2006, Nature Cell Biology.

[36]  R Nair,et al.  Is IgA nephropathy the commonest primary glomerulopathy among young adults in the USA? , 2006, Kidney international.

[37]  C. Putterman,et al.  Proinflammatory Effects of Tweak/Fn14 Interactions in Glomerular Mesangial Cells1 , 2006, The Journal of Immunology.

[38]  P. Bruneval,et al.  Podocyte involvement in human immune crescentic glomerulonephritis. , 2005, Kidney international.

[39]  W. Kriz,et al.  Pathways to nephron loss starting from glomerular diseases-insights from animal models. , 2005, Kidney international.

[40]  Kevin V Lemley,et al.  Podocytopenia and disease severity in IgA nephropathy. , 2002, Kidney international.

[41]  C. Smith,et al.  A novel TNF receptor family member binds TWEAK and is implicated in angiogenesis. , 2001, Immunity.

[42]  S. Thorgeirsson,et al.  The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. , 2000, The American journal of pathology.

[43]  Y. Hsu,et al.  TWEAK, a New Secreted Ligand in the Tumor Necrosis Factor Family That Weakly Induces Apoptosis* , 1997, The Journal of Biological Chemistry.

[44]  G. D'Amico,et al.  The commonest glomerulonephritis in the world: IgA nephropathy. , 1987, The Quarterly journal of medicine.

[45]  M. Uhlén,et al.  Neuronal proteins are novel components of podocyte major processes and their expression in glomerular crescents supports their role in crescent formation. , 2013, Kidney international.

[46]  J. Carrero,et al.  Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[47]  J. Davin.  Pathogenesis of IgA nephropathy. , 1995, Acta clinica Belgica.

[48]  P. Zucchelli,et al.  [IgA nephropathy]. , 1985, Medicina clinica.